Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening and early detection of prostate cancer will decrease morbidity and mortality from prostate cancer: the

M K Brawer1

  • 1Department of Urology, University of Washington, Seattle 98195, USA.

European Urology
|January 1, 1996
PubMed
Summary

Early detection of prostate cancer through screening, including digital rectal exams and prostate-specific antigen testing, is crucial for improving survival rates. Despite challenges like overdetection, these programs are vital for reducing cancer mortality.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Evidence: Non-metastatic prostate cancer.

The Western journal of medicine·2008
Same author

Modern brachytherapy for localized prostate cancers: the northwest hospital (Seattle) experience.

Reviews in urology·2006
Same author

Letter from the editors of reviews in urology.

Reviews in urology·2006
Same author

Evaluation and treatment of men with biochemical prostate-specific antigen recurrence following definitive therapy for clinically localized prostate cancer.

Reviews in urology·2006
Same author

Readership survey: reviews in urology.

Reviews in urology·2006
Same author

New urologic strategies explored at jackson hole: highlights from the 20th annual jackson hole urologic conference january 22-28, 2000, jackson hole, wyo.

Reviews in urology·2006

Area of Science:

  • Oncology
  • Urology
  • Public Health

Background:

  • Prostate cancer is the most common male malignancy and a leading cause of cancer death.
  • There is a critical need for effective strategies to reduce prostate cancer incidence, improve treatment, and enable early detection.

Purpose of the Study:

  • To evaluate the effectiveness of early detection programs for prostate cancer.
  • To highlight the significance of timely diagnosis in improving patient outcomes.

Main Methods:

  • Implementing early detection programs that combine digital rectal examination (DRE).
  • Utilizing prostate-specific antigen (PSA) level testing for screening.
  • Analyzing the detection rates of clinically relevant prostate cancer.

Related Experiment Videos

Main Results:

  • Early detection programs have shown a significant rate of identifying clinically relevant prostate cancer.
  • Diagnosis at an earlier, curable stage is achievable through these screening methods.

Conclusions:

  • Despite potential issues like overdetection and financial burden, early detection programs are essential for significantly impacting prostate cancer mortality.
  • Screening approaches incorporating DRE and PSA testing are warranted for widespread implementation.